Arrhythmias & electrophysiologyRandomised controlled trial

Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III

EuropacePublished

  • Cluster-randomised trial
  • 16 primary care centres

Authors' conclusion

Opportunistic screening increased participation among invited individuals and identified a higher-risk population, but its overall population reach was limited by incomplete eligibility assessment.

Study context

Population
Individuals aged 75–76 years, primary care centres in Region Värmland, Sweden
Participants
1,390 vs 1,312
Comparison
Opportunistic vs systematic atrial fibrillation (AF) screening
  • Opportunisticn = 1,390
  • Systematicn = 1,312reference
Primary endpoint
Participation in AF screening

Primary result

As reported in the abstract

Participation among invited eligible individuals

P < 0.005

Further findings

Overall population reach

P < 0.005

denominator Systematic 1,437 · Opportunistic 1,479

  • Overall population reach: lower reach with opportunistic, due to incomplete assessment for invitation

CV risk burden of participants

Opportunistic participants had higher CV risk burden (more hypertension, diabetes); CHA2DS2-VASc score opportunistic vs systematic
3.99 vs. 3.60; P < 0.005

Exclusion rates

Exclusion rates higher with opportunistic vs systematic screening, mainly due to previously diagnosed AF and cognitive impairment
18.7% vs. 8.7%; P < 0.005

Original publication

Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III. Europace. Published 30 August 2026. doi:10.1093/europace/euag214

Summarised from the published abstract; every number is checked against it